Children’s Cancer Institute Seminar Series 2015
Professor Ursula Kees
Head, Division of Children’s Leukaemia and Cancer Research, Telethon Kids Institute, University of Western Australia and Consultant, Princess Margaret Hospital for Children, Perth, WA
New therapies for patients with high-risk leukaemia
As principle investigator on paediatric cancer studies, Prof Kees focuses on leukaemia in infants and children, brain tumours and NUT midline carcinoma, an incurable disease in children and adults that leads to death within months from diagnosis.
She collaborates very closely with the clinical team at Princess Margaret Hospital to translate the results from the laboratory-based research programs. To identify novel therapies for patients she is combining large-scale drug screening and genome-wide sequencing techniques. The pre-clinical models for leukaemia, brain tumours and NUT midline carcinoma are designed to identify innovative therapies. Her translational research focuses on better diagnostic tools and bringing novel drug combinations to the clinic. She co-directs large scale biology studies of the Children’s Oncology Group to dissect the molecular changes that underpin paediatric malignancies.